The risk assessment of mercury (Hg), in both humans and wildlife, is made challenging by great variability in exposure and health effects. Though disease risk arises following complex interactions between genetic ("nature") and environmental ("nurture") factors, a majority of Hg studies thus far have focused solely on environmental factors. In recent years ecogenetic-based studies have emerged and have started to document that genetic and epigenetic factors may indeed influence the toxicokinetics and/or toxicodynamics of Hg. The purpose of this paper is to review these studies, to discuss their utility in terms of Hg risk assessment, management and policy, and to offer our perspectives on fruitful areas of future research. In brief, epidemiological studies on populations exposed to inorganic Hg (e.g., dentists and miners) or methylmercury (e.g., fish consumers) are
INTRODUCTION
Ecogenetics evolved from the field of pharmacogenetics and has been defined by Costa and Eaton as the "study of critical genetic determinants that dictate susceptibility to environmentally influenced adverse health effects" [1] . Contemporary ecogenetic thinking emerged in the mid to late 20 th century with seminal contributions by Motulsky [2] , Omenn and Motulsky [3] , and Grandjean [4] reasoning that individual susceptibilities have an ecogenetic basis and that consideration of ecogenetics can have profound implications for science and policy. Only in recent years, however, has this field grown substantially. This is largely due to rapid technological advancements in the laboratory, a deeper understanding of molecular and functional genetics, and the realization that epigenetic processes serve as an interface between an organism's rapidly changing environment and its relatively fixed genome. In both ecotoxicology [5] and human health [1, 6] , it is now widely accepted that disease risk and progression arises from a complex interplay between genetic ("nature") and environmental ("nurture") factors ( Figure 1 ).
Mercury (Hg) is an environmental contaminant of global concern whose risk assessment and management can benefit from an ecogenetic understanding. Reports published by expert panels and leading scientists have concluded that real-world exposure to Hg may be associated with a range of sub-clinical and adverse health outcomes in humans and wildlife [7] [8] [9] [10] . These reports acknowledge that there exists tremendous inter-individual and inter-species variation in exposure and hazard, and that complex gene-environment interactions may underlie such variation but as of yet remain unresolved. With no resolution to such variability, decision-making is hampered and uncertain [11, 12] . Risk assessments attempt to account for variability by utilizing default uncertainty factors.
Uncertainty factors increase the margin of safety in an effort to protect sensitive subgroups, but in doing so they may still prove to be insufficient or perhaps even over-protective. As we embark upon next-generation risk assessment [12] , there is a need to harness emerging ecogenetic approaches to A c c e p ted P r e p r i nt help increase understanding of true biological variation across and within individuals and species so that uncertainty factors are refined and risk assessments improved.
To identify susceptible subgroups, ecogenetic thinking calls for attention to be paid to both environmental and genetic determinants of exposure and hazard. In ecotoxicology and human health, however, most Hg studies are focused solely on resolving environmental or exposure-related factors (e.g., what are Hg levels in fish and consumers?). While this remains a requisite step in Hg's risk assessment, it has limited use alone in predicting risk. Mercury science is approaching a point where ecogenetic methods may now be used to better identify susceptible groups and perhaps minimize the reliance upon uncertainty factors. In recent years an increasing number of studies have started to document that genetic and epigenetic factors may influence the toxicokinetics and/or toxicodynamics of Hg. For example, a study on monozygotic and dizygotic twins revealed Hg biomarker variance stems from both additive genetic effects and unshared environmental effects with the genetic component explaining an estimated 30% of variance in Hg concentrations [13] . Epidemiological studies on populations exposed to inorganic Hg (e.g., dentists and miners) or methylmercury (MeHg) (e.g., fish-consuming populations) are showing that polymorphisms in a number of environmentally responsive genes can explain variations in Hg biomarker values and health outcomes (Tables 1 and 2 ).
Studies on mammalian wildlife and humans are showing MeHg exposures to be related to epigenetic marks (Table 3) . These findings, and many others, are beginning to increase our understanding of Hg's mechanisms of actions and potentially identify candidate biomarkers of susceptibility. In doing so, this may lead to more accurate risk assessments and improved decision-making. The purpose of this paper is to review these studies, and to discuss their utility in terms of Hg risk assessment, management and policy, and to offer our perspectives on fruitful areas of future research.
GENETIC FACTORS AND POLYMORPHISMS
Certain genetic pathways (e.g., xenobiotic metabolism, DNA repair, cell cycle) have evolved to protect the body from environmental toxicants and stressors. The genes in these pathways, referred to as environmentally responsive genes, have polymorphic variants that help organisms better cope with changing environments. In humans, approximately 0.1% of DNA (three million base pairs) is variable between individuals, and some of these polymorphic loci may render individuals more sensitive or more resistant to environmental contaminants. The most common type of genetic variability, single nucleotide polymorphism (SNP), occurs when one nucleotide is altered in the genome sequence, and the variant allele is found in at least 1% of the population. While not all SNPs have known phenotypic effects, many have been shown to confer resistance or susceptibility to disease [14] , impact drug metabolism and efficacy [15] , and influence toxicokinetics and toxicity of chemicals including heavy metals. The latter has been well studied for lead [16, 17] , arsenic [18, 19] , and beryllium [20, 21] . For
Hg, as outlined below, the knowledge of gene-Hg relationships is now growing.
Gene classes important to Hg toxicokinetics
Genes involved in the toxicokinetics of Hg include those underlying glutathione (GSH) function (e.g., glutathione s-transferases, GSTs), proteins that bind and transport Hg (e.g., selenoproteins; metallothioneins, MTs), and xenobiotic transporters (e.g., multi-drug resistance proteins, MRPs).
Polymorphisms in these environmentally responsive genes are ubiquitous across populations, and thus may influence the absorption, distribution, metabolism, and elimination of Hg. Here we review key findings relating to the impact of polymorphisms in these genes and their potential to affect Hg toxicokinetics.
Glutathione. Glutathione binds inorganic Hg and MeHg enabling cellular efflux (e.g., via MRPs) and eventually fecal excretion [22] . Polymorphisms in GSH synthesis pathway genes (GCLM, GCLC, GSS, GSR) could impact the bioavailability of GSH for this process. Additionally, glutathione stransferases (GSTs; GSTP1, GSTA1, GSTM1, GSTM3, GSTT1), a highly polymorphic family of enzymes, may catalyze the conjugation reaction and/or may act as transporters of Hg-GSH conjugates [22] . In vitro it has been shown that two nonsynonymous GSTP1 SNPs (rs1695, rs1138272; note 'rs' refers to reference SNPs numbers) can alter enzyme activity and sensitivity to Hg inhibition [23] . The
A c c e p ted P r e p r i nt metabolism of Hg can be affected by variation in the expression or activity of γ-glutamyltransferase 1 (GGT1), which cleaves Hg-GSH conjugates prior to cellular uptake [24] . In mice with a Ggt1 knockout, more MeHg is excreted and less inorganic Hg is accumulated in the kidneys following treatment with the respective Hg species [25] .
Recent epidemiological studies have linked polymorphisms in GSH pathway genes to hair, blood, and urine Hg levels (Table 1 ; [16, [26] [27] [28] [29] [30] [31] ). Note that hair reflects exposure to organic Hg, blood generally reflects exposure to organic Hg (though some inorganic may be present in blood), and urine generally reflects exposure to inorganic Hg (though some of this may have been derived from organic
Hg that was demethylated inside the body). Collectively, 12 polymorphisms in 10 GSH pathway genes were genotyped in various population studies. The majority of the polymorphisms were associated with Hg concentrations in at least one study and at least one type of statistical analysis (e.g., association with median biomarker levels, effect modification on relationship between estimated exposure and biomarker concentration). Despite the use of populations with various ethnicities and Hg exposure levels, some gene-Hg relationships were similar across studies. For example, minor alleles of SNPs in glutamyl-cysteine ligase (rs17883901 in GCLC; rs41303970 in GCLM) were associated with increased MeHg biomarker levels [16, 26, 28] . In contrast, the GCLM rs41303970 minor allele was associated with higher blood, plasma and urine Hg levels in Ecuadorian gold miners [27, 31] . Not all gene-Hg relationships were consistent across studies. For example, Custodio et al. [26] found higher erythrocyte Hg levels in individuals with the minor allele of GSTP1 rs1138272 compared to polyunsaturated fatty acid levels, an indicator of fish consumption, while Engström et al. [28] observed the opposite relationship. Similar to the latter study, lower hair Hg levels were associated with minor alleles of GSTP1 rs1138272 and rs1695 in a cohort of dental professionals with fish consumption patterns similar to the US general population [29] .
Metallothionein. Metallothioneins bind metals including Hg and in doing so, influence heavy metal distribution and protect against toxicity. Two epidemiological studies have explored the impact A c c e p ted P r e p r i nt of MT and MT transcription factor (MTF) SNPs on Hg biomarkers [16, 32] . In a cohort of dental professionals, several significant interactions between exposure source and genotype were observed in models of hair Hg (MT1M rs9936741, MT1A rs8052394) and urine Hg (MT1M rs2270837, MT2A rs10636) [32] . Gundacker et al. [16] additionally found two SNPs (MT1A rs11640851, MT4 rs11643815) to be associated with higher hair Hg.
Selenoprotein. Selenoproteins buffer against Hg-induced oxidative stress via Hg binding [33, 34] .
With up to ten selenocysteine residues per protein, selenoprotein P1 (SEPP1) is particularly equipped for this task [34, 35] . The genotype of SEPP1 influences isoform prevalence and gene expression, and variation in these parameters may influence Hg sequestration and/or tissue distribution [36] [37] [38] . In a cohort of dental professionals, a regulatory-region SEPP1 SNP (rs7579 in the 3'UTR) was differentially associated with hair Hg and urine Hg levels [29] . A significant interaction between fish intake and genotype led to lower hair Hg, while genotype and dental amalgam exposure interacted to increase urine Hg among more highly exposed individuals. Both Hg exposure [33] and polymorphisms in the encoding genes [39, 40] influence expression and activity levels of glutathione peroxidases (GPX), antioxidant proteins typically containing one selenocysteine residue. Despite a plausible geneHg interaction, only two GPX polymorphisms have been studied to date, and no significant relationship was observed [29] .
Xenobiotic Transporter. Xenobiotic transporters including the multi-drug resistant protein (MRP) and organic anion transporter (OAT) families regulate cellular influx and efflux of GSH-Hg or cysteine-Hg conjugates. In a study of occupationally exposed artisanal gold miners from four countries in Africa and Asia, 18 SNPs in 8 transporter genes were studied and of these, three SNPs (MRP2 rs1885301, rs717620; LAT1 rs33916661) were linked to higher urine Hg levels in at least one population while three were associated with lower urine Hg (MRP2 rs2273697, OAT1 rs4149170; OAT3 rs4149182) [41] .
A c c e p ted P r e p r i nt
Evidence for genetic factors impacting Hg toxicodynamics
Beyond the influence of genetic polymorphisms on Hg toxicokinetics and biomarker values, growing evidence links SNPs and other types of genetic polymorphisms to variability in Hg-associated adverse health outcomes (Table 2) .
A large portion of studies to date involving the interaction of polymorphisms and Hg exposure on health outcomes stem from a single research team that has studied a cohort of male dentists and female dental assistants with occupational elemental (inorganic) Hg exposure ( [46] . Some of the additive effects between Hg exposure and genotype were gender and occupation specific. Interactions of CPOX4 were also found among male children (ages 8-18) with similar urine Hg levels to the dental cohort, though these relationships were generally not observed among female children [47] . Collectively, these studies highlight the importance of polymorphisms directly related to specific health outcomes in conferring susceptibility to Hg's toxic effects. BDNF rs6265 appears to be a key polymorphism associated with several neurobehavioral effects, and other such polymorphisms may remain unidentified.
Besides inorganic Hg, interactions between blood Hg concentrations, indicative primarily of MeHg exposure, and polymorphisms influencing adverse health outcomes or health biomarkers have been observed. The offspring of mothers with GSTM1 and GSTT1 deletions and higher blood Hg levels A c c e p ted P r e p r i nt had increased risk for low birth weight [48] . Genotype of a repeat polymorphism in matrix metalloproteinase, MMP-9, affected MMP-9 protein levels among fish-consuming Brazilians with the lowest plasma Hg levels, and higher MMP-9 levels were associated with multiple adverse cardiovascular effects [49] . In the same cohort, a MMP2 promoter polymorphism (rs243865) affected MMP-2 levels when blood Hg was accounted for [50] . Genotype of a tandem repeat polymorphism in NOS3 and blood Hg levels are linked to decreased nitric oxide production, another biomarker of cardiovascular health, among highly exposed fish-eaters in Brazil [51] . However, two NOS3 SNPs (rs2070744, rs1799983) did not impact plasma nitrite levels following fish consumption [52] .
Not all studies exploring gene-Hg interactions found significant links with the assessed health outcomes [31, [52] [53] [54] [55] [56] emphasizing the importance of polymorphism selection, Hg exposure level, and health outcome measure. Most studies with significant associations genotyped variants in pathways related to the health outcome of interest. Polymorphisms involved in Hg toxicokinetics may be less likely to impact target organ toxicity as noted by the lack of significant interactions in several studies of health outcomes and polymorphisms primarily in the GSH pathway [31, 53, 56] .
EPIGENETIC FACTORS
Epigenetics is emerging as important to the toxicity of many classes of environmental contaminants [57, 58] , including some metals [59, 60] . Epigenetics refers to factors affecting gene expression that are heritable, but occur outside of direct changes to the DNA sequence. Examples of epigenetic endpoints are histone modification, DNA methylation and RNA interference. These endpoints are affected by environmental stimuli such as chemical exposure, stress, parental behavior, and nutritional deficits. Epigenetic marks left by such stimuli can persist in tissues as cells divide in the absence of the initial stressor. This implies that exposures to chemicals at an early life stage can lead to adverse health outcomes later in life, or even in subsequent generations. These characteristics have been demonstrated in several models [57] and have important implications for environmental toxicology [5] .
The epigenetic effects of Hg is a relatively new field of inquiry, especially when compared to other contaminants such as arsenic, lead, air pollution, and endocrine disruptors [58] . The epigenome is established during development and is thought to be sensitive to environmental influences during this time. Likewise, MeHg has been proven to be a developmental neurotoxin in a number of organisms [61] including humans and wildlife [62] . Another point of epigenetic consideration is that MeHg is known to have a long latency period between exposure and adverse health outcomes. For example, at Minamata Bay in Japan, impaired cognition and dysfunctions in mood and behavior were found in adults of varying ages who did not exhibit any clinical effects following developmental, early-life exposures [63] . Longitudinal birth cohort studies from the Faroe Islands have documented that developmental exposures (as determined by cord blood Hg) can be related to later-life adverse neurological outcomes in children aged 7 and 14 years [64] . A latency period of several decades is suggestive of an epigenetic mode of action, although this has yet to be demonstrated.
Global DNA methylation
DNA methylation is a biochemical process that results in the addition of a methyl group to a nucleotide [65, 66] . A growing body of research suggests that environmentally relevant MeHg concentrations can disrupt DNA methylation in mammals (Table 3 ). This effect has been observed in both laboratory animals and field studies. Pilsner et al. [67] report an inverse relationship between brain stem Hg levels and global DNA methylation in Greenlandic male polar bears (Ursus maritimus).
Similarly, DNA methylation was reduced in the occipital cortex of juvenile male mink (Neovison vison) raised on a diet of 1 ppm MeHg for 2 months though DNA methylation was unchanged in in animals fed 2 ppm [68] . In these same mink, activity of DNA methyltransferase (DNMT), the enzyme that establishes and maintains patterns of DNA methylation in the genome, was also reduced. In primary cultures of rat cortical embryonic neural stem cells (NSCs), subtoxic concentrations of MeHg A c c e p ted P r e p r i nt were associated with reduced NSC proliferation, decreased global DNA methylation, and a slight reduction in Dnmt3b mRNA [69] . These effects persisted in daughter cells that were never directly exposed to MeHg-contaminated media. Several other studies support a link between MeHg exposure and reduced DNMT expression. Desaulniers et al. [70] report a MeHg-associated reduction in Dnmt1
and Dnmt3b mRNA in the livers of female rats exposed to MeHg during the perinatal period.
However, they did not observe any effect on global DNA methylation or levels of the important methyl donor, s-adenosylmethionine (SAM).
It is not clear whether the MeHg-associated depression in global DNA methylation observed in mammals extends to other classes of animals. In brain telencephalon of MeHg-fed yellow perch (Perca flavescens), there was no change in DNA methylation [68] . In brain cerebrums of chickens (Gallus gallus domesticus) exposed in ovo, a MeHg-dependent decrease in global DNA methylation was observed, but this trend was not statistically significant [68] . In these same chickens, there were no MeHg-dependent changes in the heart or liver. In earthworms, global DNA methylation was reduced in relation to elevated levels of Hg, arsenic (As), selenium (Se) and antimony (Sb). This relationship appeared to be mainly driven by arsenic (As), a metal with well-described epigenetic effects [58] [59] [60] , but Hg was also a contributing element [71] .
Others and we have suggested that global DNA methylation could be useful as a biomarker for exposure to Hg and other chemical agents [5, 58] . It is important to note that while global DNA methylation may be a general indicator for epigenetic stress, we are not aware of any studies that link Hg-associated global hypomethylation to specific health outcomes. In general, abnormal patterns of methylation have been associated with cancer and neurological, developmental, immunological and age-related disorders [72] . More work is required to identify which areas of the genome are affected by Hg-associated hypomethylation and what, if any, adverse health outcomes are associated with reduced methylation status, particularly in the developing embryo.
Gene specific effects
In contrast to interpreting studies concerning global changes in DNA methylation, gene specific alterations in epigenetic status may be more easily interpreted in relation to health outcomes, In an animal study, Onishchenko et al. [73] linked MeHg-associated epigenetic repression of brain-derived neurotrophic factor (BDNF) to depressive-like symptoms in young male mice. Exposure to MeHg occurred through maternal dietary supplementation from gestational day 7 until 7 days after birth.
Along with depressive-like symptoms, MeHg-exposed male offspring exhibited reduced Bdnf mRNA in the dentate gyrus. This was attributed to a repressive chromatin state at the Bdnf promotor. DNA hypermethylation was observed along with increased histone H3K27 tri-methylation at Bdnf promoter IV, and decreased histone H3 acetylation. These effects persisted in 14 month-old mice without any further exposure to MeHg. An in vitro study using mouse embryonic stem cells found that acute exposure to Hg 2+ reduces total histone protein levels and H3K27 mono-methylation [74] . The authors speculate that this may indicate transcriptional repression. Arai et al. [75] reported that the Rnd2 gene is hypermethylated in Hg-treated mouse embryonic stem cells. In contrast, Desaulniers et al. [70] found that the promoter of the tumor suppressor gene p16 INK4a was hypomethylated in MeHg exposed female rats.
In human epidemiology there are two studies that report MeHg-associated DNA methylation of specific genes. In a pilot study of 58 women, hypermethylation of the GSTM1 promoter in whole blood was found in those with blood Hg values above 2.9 μg/L [76] . In a study of 131 dental professionals, biomarkers of MeHg exposure (hair) and elemental Hg exposure (urine) were related to DNA methylation at global repetitive elements (long interspersed elements, LINE-1) and promoter regions of genes related to epigenetic processes (DNMT1) and Hg interactions (selenoproteins SEPW1
and SEPP1) [77] . Following a series of multivariable linear regressions the only statistically significant association was hypomethylation of SEPP1 with hair Hg levels among males.
Mechanisms
The mechanisms by which Hg affects epigenetic endpoints have not been resolved. In general,
Hg has a strong affinity for protein thiol and selenol groups, and this is thought to be the root cause of toxicity [78] . Accordingly, the direct and indirect targets for Hg are numerous and may include those involved in maintaining cellular homeostasis, transducing signals, and ensuring redox states [79] . Here we focus on possible mechanisms by which Hg may affect DNA methylation. We recognize that other epigenetic mechanisms may be affected by Hg (e.g., histone modification or RNA interference), though DNA methylation is the most studied epigenetic endpoint to date and the focus below ( Figure   2 ). Another potential target for Hg is SAM. S-adenosylmethionine (SAM) is regenerated from sadenosylhomocysteine (SAH) via the methionine cycle. Onishchenko et al. [60] suggest that the ratio of SAM to SAH, sometimes referred to as the methylation capacity, may be key to understanding how contaminants affect DNA methylation. A low ratio of SAM to SAH may result in a deficit of methyl groups for DNA methylation.
Other aspects of the methionine cycle are also important to both DNA methylation and Hg toxicokinetics. Methionine is an essential amino acid that serves as a penultimate methyl donor given that L-methionine is converted into SAM by the enzyme SAM synthetase. It is interesting to note that
MeHg can form conjugates with L-cysteine and the resulting MeHg-L-cysteine complex is structurally similar to methionine. In fact, it has been documented that MeHg-L-cysteine complex can act as a molecular mimic, substituting for methionine in some cellular processes [78] , including, potentially, the methionine cycle. Another potential target for Hg is methionine synthase, the enzyme that converts homocysteine to methionine. It has been speculated that methionine synthase could be involved with MeHg-associated changes to DNA methylation status [69] ; methionine synthase is inhibited by inorganic and ethylated Hg [80] , and the same may be true for MeHg. Inorganic Hg and MeHg may also bind with homocysteine, and these Hg-homocysteine conjugates are biologically transportable [81] . An epidemiological analysis of U.S. NHANES data suggest that blood Hg levels may be inversely associated with plasma homocysteine levels in younger aged boys [82] . Collectively, these studies show that Hg may affect the methionine cycle in a number of ways, and this may subsequently impact the availability of SAM for DNA methylation.
APPLICATIONS OF ECOGENETICS TO RISK ASSESSMENT
Identifying individuals and organisms susceptible to a contaminant like Hg remains at the forefront of ecological and human health risk assessment. Hg is considered a priority pollutant by agencies worldwide (e.g., US EPA, US ATSDR, Health Canada, WHO), and under the 2013 Minamata
Convention it is proposed to be phased out of many intentional-use products. Nonetheless, as a persistent chemical, Hg remains globally dispersed, and levels are projected to further increase in many areas [83] . Hg exposures to humans and wildlife will be commonplace for the foreseeable future with diet (e.g., fish, rice) and proximity to point sources or certain products (e.g., small-scale gold mining,
A c c e p ted P r e p r i nt dental amalgams) remaining prominent. For a number of ethical, legal, and social reasons, it remains judicious for us to ensure that all individuals and organisms -the average and the most sensitive -are identified and protected. In this section, we discuss how the ecogenetic research reviewed in this paper may be used to help improve the risk assessment of Hg and ultimately lead to better decision-making.
Uncertainty factors
Risk assessors in both ecotoxicology and human health apply uniform uncertainty factors to account for inherent variability [84, 85] . A c c e p ted P r e p r i nt would also decrease exposure to key nutrients in fish [87] . µg/g among individuals with the CC genotype compared with 2.14 µg/g (CT) and 0.74 µg/g (TT).
Exposure biomarkers
A major limitation in the risk assessment of Hg is the tremendous inter-individual variability observed in exposure biomarkers. For example, in humans a hair to blood ratio of 250 is used in risk assessment, but this value can vary widely among populations (means: 140 to 370) and individuals (maximum ratio >600) [88] [89] [90] . Calculated half-lives of MeHg range from 33-120 days in hair, days in blood cells, and 47-130 days in plasma [91] . Variable inorganic Hg retention has also been observed in humans [92] and mice [93] , the latter of which is strain and gender dependent. Similarly for wildlife, Hg levels in samples collected non-invasively such as fur and feathers can vary widely when compared to internal doses measured in blood or organs [94, 95] . When such data are utilized in validated exposure assessment models, there can exist great discrepancy between the modeled A c c e p ted P r e p r i nt relationships and measured biomarker values. For example, in a re-analysis of fish consumption surveys and measured biomarker values from a number of human groups worldwide, Canuel et al. [96] documented that the normative risk assessment of MeHg yielded results that were highly variable (68% to 573%) in terms of relating modeled hair Hg with measured hair Hg. A number of factors may help explain this variability (e.g., recall bias, instrument error), though as discussed by the authors, it is also quite likely that unresolved inter-individual genetic differences feature prominently. As outlined in Table 1 , the first ecogenetic studies are showing that polymorphisms in genes within the glutathione, metallothionein, selenoprotein, and xenobiotic transporter families may affect Hg biomarker values, and it is hoped that in the future, consideration of such information may help improve the interpretation of exposure biomarkers, as discussed in the review paper by Dorne et al. [97] .
Inter-species differences
The intra-species differences in Hg toxicokinetics and toxicodynamics observed in humans will also exist for fish and wildlife, but have received minimal study. More attention is concerned with differences across species. For example, Heinz et al. [98] injected MeHg into eggs of 26 bird species, found variable dose-response curves and calculated LC50s, and provided some discourse on sensitivity differences based on taxonomy. For marine mammals, polar bears are exposed to some of the greatest Hg levels among all organisms (liver concentrations >100 ppm dry weight), but surprisingly low levels were found in their brains (<1 ppm dry weight measured but >20 ppm expected) [99] . Within the Mustelidae family, mink and river otters inhabit common ecosystems but seem to have different abilities to metabolize Hg in the brain. Compared to otters, mink have a lowered ability to demethylate organic Hg and accumulate selenium in the brain [100] . Similar differences in demethylation and selenium accumulation have also been found in common loons and bald eagles [101] .
In these selected examples, the inter-species differences have near-exclusively been discussed in consideration of factors such as natural history and physiology, though it is likely that ecogenetics also play a role. As an example, one of us previously documented that two amino acid changes in the avian A c c e p ted P r e p r i nt aryl hydrocarbon receptor could help predict species sensitivity to dioxin-like compounds [102] . It needs to be wondered if similar genetic differences may be uncovered for Hg to help improve ecological risk assessment.
Nutrient-toxicant interactions
As mentioned previously fish are not only a major source of MeHg but they are also an important source of essential nutrients, such as omega-3 fatty acids, that may have positive effects on physiological systems adversely affected by MeHg. A number of nutrients or nutritional factors, such as selenium, cysteine, protein, milk, and vitamin E have been shown to affect the toxicokinetics and toxicodynamics of Hg [103] . Much of this evidence has been gleaned from in vitro or animal/wildlife studies, though within human epidemiology there remains continued debate concerning the protective effects of various nutrients on MeHg-associated adverse health outcomes [9] . Perhaps some of this debate stems from the fact that many nutrients, like toxicants, have a strong ecogenetic basis [104] .
For example, an increase in plasma selenium concentrations following a six week supplementation trial varied significantly based on genotype of two SEPP1 SNPs (rs7579, rs3877899), body mass index, and interaction between body mass index and genotype [36] . Within epigenetics, there exist a number of studies documenting that altered exposure of animals and people to dietary methyl donors (e.g., folate, choline) related to predicted alterations in DNA methylation [105] . While the task of linking ecogenetic data from Hg and a number of nutrients into a single study to help tease apart risk-benefits seems daunting, advances in statistical modeling may prove useful.
Vulnerable windows and latencies
MeHg is a developmental toxicant, known to exhibit a long latency of effect. This makes it difficult to causally relate early-life exposures and later-life health impacts, and thus represents a major challenge to risk assessment. Though much more research is needed, epigenetics is starting to provide mechanistic evidence to bridge the temporal gap between exposure and disease. Hg-induced changes in DNA methylation, for example, may result in gene expression changes that are persistent and A c c e p ted P r e p r i nt traceable. For example, in a study of neural stem cells that were exposed to MeHg, changes in DNA methylation were found in cells directly exposed but also in their daughter cells that were never exposed to MeHg [69] . In other words, altered DNA methylation may serve as a 'memory' of contaminant exposure [66] . This could potentially help identify vulnerable windows of susceptibility to toxic effects.
CONCLUDING REMARKS
Mercury is a contaminant of global concern, and will remain so in the foreseeable future. The risk assessment of Hg and subsequent management decisions have been hampered owing to great variability in exposure and health effect, in both humans and wildlife. Using MeHg exposure in humans as an example, there exists continued debate concerning inter-individual variation in adverse neurodevelopmental outcomes (e.g., differing outcomes in Faroe vs. Seychelles studies), progression of cardiovascular disease (e.g., hypertension risk), and latencies between exposure and health effect which can range from weeks to years as was observed following the Minamata Bay incident [8] [9] [10] .
To date, most studies have tried to account for variability by considering, for example, pertinent biological or environmental factors such as age and gender, and co-exposures to other toxicants and nutrients; inclusion of such covariates has been met with limited success. There is now growing evidence, as highlighted in this paper, that an ecogenetic understanding (i.e., genetic polymorphisms, epigenetic processes) may help uncover underlying mechanisms of action and better identify susceptible sub-populations. The field is at its infancy, and moving forward there are a number of potentially exciting avenues of research. Below we provide a few examples for both genetics and epigenetics.
In genetic studies, first, discrepancies among epidemiological studies seemingly related to differences in exposure characteristics (e.g., dose, source, Hg species, duration), population genotype frequencies, Hg biomarkers analyzed, statistical modeling, and statistical power highlight the need for improved study designs and communication among research teams. Standardizing methods across research groups for estimating Hg exposures (e.g., fish consumption surveys versus measuring fish biomarkers in blood), Hg body burden (collection of all three main biomarkers), and toxicity (e.g., neurobehavioral test batteries) whenever possible would improve comparability of studies and increase weight of evidence for important genetic factors. Second, the total number of polymorphisms studied to date has been small with the majority focused on GSH-pathway genes. Hypothesis-driven, candidate gene research involving environmentally-responsive genes should continue, though gene selection could be organized in a pathway-based manner (i.e., multiple genes in a given pathway In epigenetic studies, first, the total number of studies concerned with Hg is limited and thus there is a great need to perform the most basic studies to increase the knowledge base. For example, research on whether Hg affects DNMT activity, methionine synthase activity, and SAM levels needs to be resolved at the observational, experimental, and mechanistic levels. Global DNA methylation data is of limited use, and future work will need to focus upon methylation of specific gene targets. Beyond DNA methylation, there exist other epigenetic markers (e.g., histone modifications) that have received very little attention in terms of Hg exposure. Without such basic knowledge, tackling and interpreting the outcomes of more sophisticated research outcomes will be challenging. Second, given the promise of epigenetics as a mechanism to help explain long latencies and transgenerational effects, carefully designed longitudinal human studies and multi-generational wildlife studies will need to be conducted.
A c c e p ted P r e p r i nt Third, like with genetics, there now exist platforms by which thousands of DNA methylation marks can be interrogated. Use of such epigenome-wide association technologies will reveal a greater picture of regions of the epigenome targeted by Hg and may provide mechanistic links to toxic outcomes.
Mercury is a contaminant that is being acted upon by decision makers worldwide, from local settings to the global level. As we embark upon activities that will assess the efficacy of these decisions, we will need to rely upon scientific advancements and next-generation risk assessments. It will be necessary for us to incorporate emerging ecogenetic approaches to help increase understanding of true biological variation across and within species so that uncertainty factors are refined and risk assessments improved. The tools and basic knowledge for conducting such studies are now at our disposal. Such activities will need to be conducted with a constant reminder that disease risk and progression arise following complex interactions between genetic ("nature") and environmental ("nurture") factors over time. A c c e p ted P r e p r 
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